StocksMedium•12 November 2026•
1 min read
Aveanna Healthcare Beats Q3 Estimates and Raises Full-Year 2026 Guidance
Key Facts
1Aveanna Healthcare delivered a Q3 beat with adjusted EBITDA growing 25% year-over-year.
2The company raised its full-year 2026 revenue and adjusted EBITDA guidance.
Aveanna Healthcare Holdings Inc. delivered Q3 2026 financial results that exceeded analyst estimates, with adjusted EBITDA growing 25% year-over-year. Seeking Alpha reported that the company subsequently raised its full-year 2026 revenue and adjusted EBITDA guidance.
The company demonstrated significant operating leverage as margins expanded to 14.4%, leading to improved cash flow despite its existing debt load. Shares of AVAH closed at $13.09 on November 11, 2026, having reached a session high of $13.42 earlier that day.